GLEN Industries
GLEN Industries
HealthcareKey Fundamentals
SMEPharmaceuticalsHealthcareTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
Growth Rate
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 84 | 87 | 96 | 108 |
| Expenses | 66 | 64 | 76 | 90 |
| Operating Profit | 18 | 23 | 19 | 18 |
| OPM % | 21% | 26% | 20% | 17% |
| Other Income | 1 | 0 | 1 | 1 |
| Interest | 4 | 6 | 5 | 5 |
| Depreciation | 4 | 4 | 4 | 4 |
| PBT | 11 | 13 | 11 | 11 |
| Tax % | 25% | 26% | 25% | 23% |
| Net Profit | 8 | 10 | 8 | 8 |
| EPS in Rs | 4.84 | 5.53 | 3.45 | 3.41 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 92 | 115 | 140 | 166 | 199 |
| Expenses | 81 | 99 | 115 | 126 | 162 |
| Operating Profit | 11 | 16 | 25 | 40 | 37 |
| OPM % | 12% | 14% | 18% | 24% | 19% |
| Other Income | 3 | -2 | 0 | 1 | 2 |
| Interest | 4 | 6 | 7 | 9 | 9 |
| Depreciation | 5 | 6 | 6 | 7 | 8 |
| PBT | 5 | 3 | 11 | 24 | 22 |
| Tax % | 27% | 44% | 25% | 25% | 24% |
| Net Profit | 4 | 1 | 9 | 18 | 16 |
| EPS in Rs | 35.62 | 14.42 | 82.46 | 10.37 | 6.86 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 18 | 32 |
| Reserves | 17 | 31 | 40 | 41 | 107 |
| Borrowings | 77 | 86 | 94 | 133 | 121 |
| Other Liabilities | 22 | 19 | 26 | 23 | 30 |
| Total Liabilities | 116 | 137 | 161 | 214 | 291 |
| Fixed Assets | 55 | 73 | 81 | 108 | 108 |
| CWIP | 1 | 0 | 0 | 1 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 60 | 64 | 80 | 106 | 170 |
| Total Assets | 116 | 137 | 161 | 214 | 291 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -14 | 11 | 14 | 6 | 6 |
| Investing | -22 | -15 | -13 | -35 | -18 |
| Financing | 34 | 4 | -2 | 30 | 11 |
| Net Cash Flow | -2 | 0 | -1 | 1 | -1 |
| Free Cash Flow | -29 | -2 | 0 | -29 | -14 |
| CFO/OP | -124 | 75 | 57 | 20 | 32 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 61 | 52 | 69 | 68 | 68 |
| Inventory Days | 192 | 192 | 184 | 252 | 240 |
| Days Payable | 34 | 42 | 51 | 25 | 41 |
| Cash Conversion Cycle | 219 | 202 | 203 | 294 | 267 |
| Working Capital Days | 6 | -6 | 4 | 4 | 25 |
| ROCE % | — | 10% | 15% | 20% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GLEN Industries insights
51 extracted metrics + investor summaries across FY22–FY26.
Documents
Frequently Asked Questions about GLEN Industries
What does GLEN Industries Ltd do?
Where is GLEN Industries Ltd (544444) listed?
Which sector does GLEN Industries Ltd belong to?
What is the market capitalisation of GLEN Industries Ltd?
What is the PE ratio of GLEN Industries Ltd?
What is the 52-week high and low of GLEN Industries Ltd?
What is the Return on Equity (ROE) of GLEN Industries Ltd?
Company Information
Incorporated in 2007, Glen Industries Limited (GIL) is engaged in the manufacturing of eco-friendly food packaging and service products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544444.md for GLEN Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.